Lunit is a publicly-traded firm that specializes in the development of medical AI software that is designed to assist in the fight against cancer. Early detection is a key factor in determining the survival rate of cancer patients, and Lunit’s cancer screening AI helps medical professionals to identify it in its earliest stages. Lunit INSIGHT is capable of detecting abnormalities in chest x-rays with an accuracy rate of up to 97-99%, which is far higher than what the human eye can detect. This technology is invaluable in helping doctors to identify potential issues that would otherwise go unnoticed.
In addition, Lunit SCOPE uses AI to predict how a patient will respond to treatment, allowing doctors to make informed decisions about the best course of action. This technology is helping to revolutionize the way cancer is treated, and is providing medical professionals with the tools they need to give their patients the best possible care.